127 related articles for article (PubMed ID: 15193436)
1. Overexpression through amplification of genes in chromosome region 17p11.2 approximately p12 in high-grade osteosarcoma.
van Dartel M; Redeker S; Bras J; Kool M; Hulsebos TJ
Cancer Genet Cytogenet; 2004 Jul; 152(1):8-14. PubMed ID: 15193436
[TBL] [Abstract][Full Text] [Related]
2. Amplification and overexpression of genes in 17p11.2 ~ p12 in osteosarcoma.
van Dartel M; Hulsebos TJ
Cancer Genet Cytogenet; 2004 Aug; 153(1):77-80. PubMed ID: 15325100
[TBL] [Abstract][Full Text] [Related]
3. COPS3 amplification and clinical outcome in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
[TBL] [Abstract][Full Text] [Related]
4. Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma.
van Dartel M; Cornelissen PW; Redeker S; Tarkkanen M; Knuutila S; Hogendoorn PC; Westerveld A; Gomes I; Bras J; Hulsebos TJ
Cancer Genet Cytogenet; 2002 Dec; 139(2):91-6. PubMed ID: 12550767
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel candidate oncogenes in chromosome region 17p11.2-p12 in human osteosarcoma.
Both J; Wu T; Bras J; Schaap GR; Baas F; Hulsebos TJ
PLoS One; 2012; 7(1):e30907. PubMed ID: 22292074
[TBL] [Abstract][Full Text] [Related]
6. Malignant astrocytoma-derived region of common amplification in chromosomal band 17p12 is frequently amplified in high-grade osteosarcomas.
Hulsebos TJ; Bijleveld EH; Oskam NT; Westerveld A; Leenstra S; Hogendoorn PC; Bras J
Genes Chromosomes Cancer; 1997 Apr; 18(4):279-85. PubMed ID: 9087567
[TBL] [Abstract][Full Text] [Related]
7. SAS is amplified predominantly in surface osteosarcoma.
Noble-Topham SE; Burrow SR; Eppert K; Kandel RA; Meltzer PS; Bell RS; Andrulis IL
J Orthop Res; 1996 Sep; 14(5):700-5. PubMed ID: 8893761
[TBL] [Abstract][Full Text] [Related]
8. Molecular and transcriptional characterization of the novel 17p11.2-p12 amplicon in multiple myeloma.
Fabris S; Todoerti K; Mosca L; Agnelli L; Intini D; Lionetti M; Guerneri S; Lambertenghi-Deliliers G; Bertoni F; Neri A
Genes Chromosomes Cancer; 2007 Dec; 46(12):1109-18. PubMed ID: 17823926
[TBL] [Abstract][Full Text] [Related]
9. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.
Squire JA; Pei J; Marrano P; Beheshti B; Bayani J; Lim G; Moldovan L; Zielenska M
Genes Chromosomes Cancer; 2003 Nov; 38(3):215-25. PubMed ID: 14506695
[TBL] [Abstract][Full Text] [Related]
10. Characterization of PMP22 expression in osteosarcoma.
van Dartel M; Hulsebos TJ
Cancer Genet Cytogenet; 2004 Jul; 152(2):113-8. PubMed ID: 15262428
[TBL] [Abstract][Full Text] [Related]
11. Infrequent but high-level amplification of 17p11.2 approximately p12 in human glioma.
van Dartel M; Leenstra S; Troost D; Hulsebos TJ
Cancer Genet Cytogenet; 2003 Jan; 140(2):162-6. PubMed ID: 12645656
[TBL] [Abstract][Full Text] [Related]
12. Expression analysis of the PMP22 gene in glioma and osteogenic sarcoma cell lines.
Hühne K; Park O; Liehr T; Rautenstrauss B
J Neurosci Res; 1999 Dec; 58(5):624-31. PubMed ID: 10561690
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Properties of Candidate Oncogenes in Chromosome Region 17p11.2p12 in Human Osteosarcoma.
Both J; Wu T; Ten Asbroek AL; Baas F; Hulsebos TJ
Cytogenet Genome Res; 2016; 150(1):52-59. PubMed ID: 27846620
[TBL] [Abstract][Full Text] [Related]
14. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
[TBL] [Abstract][Full Text] [Related]
15. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma.
Pasic I; Shlien A; Durbin AD; Stavropoulos DJ; Baskin B; Ray PN; Novokmet A; Malkin D
Cancer Res; 2010 Jan; 70(1):160-71. PubMed ID: 20048075
[TBL] [Abstract][Full Text] [Related]
16. Sporadic amplification of the MYC gene in human osteosarcomas.
Ladanyi M; Park CK; Lewis R; Jhanwar SC; Healey JH; Huvos AG
Diagn Mol Pathol; 1993 Sep; 2(3):163-7. PubMed ID: 8287230
[TBL] [Abstract][Full Text] [Related]
17. Comparative genomic hybridization of low-grade central osteosarcoma.
Tarkkanen M; Böhling T; Gamberi G; Ragazzini P; Benassi MS; Kivioja A; Kallio P; Elomaa I; Picci P; Knuutila S
Mod Pathol; 1998 May; 11(5):421-6. PubMed ID: 9619593
[TBL] [Abstract][Full Text] [Related]
18. Integrated assessment of potential value of erbB-2 amplification or expression status as novel therapy target in Chinese children and adolescents with osteosarcoma.
Shang J; Bi ZG; Ji HF; Wang WB
Chin Med J (Engl); 2009 Jul; 122(13):1521-4. PubMed ID: 19719941
[TBL] [Abstract][Full Text] [Related]
19. Analysis of segmental duplications, mouse genome synteny and recurrent cancer-associated amplicons in human chromosome 6p21-p12.
Martin JW; Yoshimoto M; Ludkovski O; Thorner PS; Zielenska M; Squire JA; Nuin PA
Cytogenet Genome Res; 2010 Jun; 128(4):199-213. PubMed ID: 20453501
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of allelic imbalance at the c-kit gene locus and c-kit overexpression by immunohistochemistry in pediatric osteosarcomas.
Entz-Werlé N; Marcellin L; Gaub MP; Guerin E; Schneider A; Berard-Marec P; Kalifa C; Brugiere L; Pacquement H; Schmitt C; Tabone MD; Jeanne-Pasquier C; Terrier P; Dijoud F; Oudet P; Lutz P; Babin-Boilletot A
J Clin Oncol; 2005 Apr; 23(10):2248-55. PubMed ID: 15800315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]